Literature DB >> 7605656

Radioprotective effect of local administration of lysine-vasopressin and triglycyl-lysine-vasopressin on the rectal mucosa in rats.

G Bjelkengren1, K F Aronsen, N E Augustsson, S Borgström, C Lindström, G Nylander.   

Abstract

Reactions from the rectal mucosa often give rise to troublesome side-effects during and after radiotherapy in the pelvic region. Local vasoconstriction in the rectal mucosa will cause an ischemia which will decrease the sensitivity of the mucosal cells to radiation and thereby these side-effects can be reduced. Triglycyl-lysine-vasopressin applied rectally in 1% Blanose solution gave in the present study significant radioprotection of the rectal mucosa in the doses of 0.8, 1.6, and 3.2 mg. These doses are, however, very high. Triglycyl-lysine-vasopressin in 1.2% Natrosol solution in a dose of 128 micrograms did not show any certain protective effects. However lysine-vasopressin in 1.2% Natrosol solution in a dose of 16 micrograms gave significant radioprotection of the rectal mucosa. This dose level has in a previous study not given any significant effects on the systemic circulation. Lysine-vasopressin in Natrosol solution seems to be a suitable combination for further studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605656     DOI: 10.3109/02841869509094012

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  2 in total

1.  Local radiotherapy of exposed murine small bowel: apoptosis and inflammation.

Authors:  Andrea Polistena; Louis Banka Johnson; Salomé Ohiami-Masseron; Lena Wittgren; Sven Bäck; Charlotte Thornberg; Virgil Gadaleanu; Diya Adawi; Bengt Jeppsson
Journal:  BMC Surg       Date:  2008-01-03       Impact factor: 2.102

2.  Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model.

Authors:  Louis Banka Johnson; Amjid Ali Riaz; Diya Adawi; Lena Wittgren; Sven Bäck; Charlotte Thornberg; Nadia Osman; Virgil Gadaleanu; Henrik Thorlacius; Bengt Jeppsson
Journal:  BMC Surg       Date:  2004-09-13       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.